New York's 340B changes could cost providers $30M and 300 jobs

Some New York hospitals and nonprofit healthcare organizations say a change in the way the state manages the 340B prescription drug program could lead to losses of up to 300 jobs and $30 million, Buffalo Business First reported Feb 8.

Read the full post at Becker's Hospital Review - Healthcare News